A genome-wide study on gene-nutrient interactions for hyperuricemia in a large Korean cohort (KoGES)

韩国大型人群高尿酸血症基因-营养相互作用的全基因组研究(KoGES)

阅读:1

Abstract

This study aimed to identify novel genetic variants associated with hyperuricemia risk across multiple nutrients by assessing significant gene-nutrient interactions using large-scale genome-wide association study (GWAS) data in the Korean population. A total of 48,007 individuals from the Korean Genome and Epidemiology Study dataset were included in the GWAS. Dietary intake was evaluated using a food frequency questionnaire. To identify genomic loci that interact with specific nutrients influencing hyperuricemia risk, we conducted a GWAS followed by gene-nutrient interaction analyses of genome-wide significant single-nucleotide polymorphisms (SNPs). Two SNPs with significant gene-nutrient interactions for specific nutrients were identified: rs113206751 in the Membrane-Associated Ring-CH-Type Finger 1 (MARCH1) gene and rs9393235 in the Neuroblastoma-Associated Transcript 1 (NBAT1) gene near the prolactin (PRL) gene. Among individuals consuming vitamin A above the dietary reference intake (DRI), carriers of the minor allele (A) at MARCH1-rs113206751 had a higher risk of hyperuricemia than those with the reference allele (-, no insertion) (odds ratio [OR] 1.63, 95% confidence interval [CI] 1.38-1.93, p: 1.01 × 10(- 8), interaction p: 1.22 × 10(- 6)). Among individuals consuming potassium above the DRI, carriers of the minor allele (G) at NBAT1/PRL-rs9393235 showed an increased risk of hyperuricemia than those with the reference allele A (OR 3.14, 95% CI 2.09-4.71, p: 3.69 × 10(- 8), interaction p: 1.21 × 10(- 5)). These findings suggest potential gene-nutrient interactions between MARCH1 and vitamin A, as well as between NBAT1/PRL and potassium, in relation to hyperuricemia risk. However, these findings may have limited generalizability beyond the Korean population studied and require validation in more diverse populations. This study emphasizes genomic-nutritional integration for personalized hyperuricemia management.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。